Showing 1 - 20 results of 21 for search 'Bjermer, L', query time: 0.06s
Refine Results
-
1
-
2
-
3
Type 2 Inflammatory Biomarker Response After Exercise Challenge Testing by Tufvesson E, Stenberg H, Ankerst J, Bjermer L
Published 2020-08-01
Article -
4
Asthma referrals: a key component of asthma management that needs to be addressed by Price D, Bjermer L, Bergin DA, Martinez R
Published 2017-07-01
Article -
5
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA) by Bjermer L, Kuna P, Jorup C, Bengtsson T, Rosenborg J
Published 2015-02-01
Article -
6
-
7
-
8
Bronchodilator response of advanced lung function parameters depending on COPD severity by Jarenbäck L, Eriksson G, Peterson S, Ankerst J, Bjermer L, Tufvesson E
Published 2016-11-01
Article -
9
A new approach to assess COPD by identifying lung function break-points by Eriksson G, Jarenbäck L, Peterson S, Ankerst J, Bjermer L, Tufvesson E
Published 2015-10-01
Article -
10
Effects of baseline symptom burden on treatment response in COPD by Martinez FJ, Abrahams RA, Ferguson GT, Bjermer L, Grönke L, Voß F, Singh D
Published 2019-01-01
Article -
11
-
12
Lung Fibroblasts from Chronic Obstructive Pulmonary Disease Subjects Have a Deficient Gene Expression Response to Cigarette Smoke Extract Compared to Healthy by Garcia-Ryde M, van der Burg NMD, Larsson CE, Larsson-Callerfelt AK, Westergren-Thorsson G, Bjermer L, Tufvesson E
Published 2023-12-01
Article -
13
Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD by Tufvesson E, Radner F, Papapostolou G, Jarenbäck L, Jönsson S, Nihlén U, Ankerst J, Tunsäter A, Peterson S, Bjermer L, Eriksson G
Published 2020-11-01
Article -
14
Feno and blood eosinophils as biomarkers in predicting asthma exacerbations by Rastogi, S, Bosnic-Antievich, S, Pavord, I, Roche, N, Halpin, D, Bjermer, L, Usmani, O, Brusselle, G, Ming, S, Halim, S, Gopalan, G, Price, D
Published 2017Conference item -
15
Current evidence and future research needs for FeNO measurement in respiratory diseases by Bjermer, L, Alving, K, Diamant, Z, Magnussen, H, Pavord, I, Piacentini, G, Price, D, Roche, N, Sastre, J, Thomas, M, Usmani, O
Published 2014Journal article -
16
Current evidence and future research needs for FeNO measurement in respiratory diseases. by Bjermer, L, Alving, K, Diamant, Z, Magnussen, H, Pavord, I, Piacentini, G, Price, D, Roche, N, Sastre, J, Thomas, M, Usmani, O
Published 2014Journal article -
17
Severe eosinophilic asthma: a roadmap to consensus. by Buhl, R, Humbert, M, Bjermer, L, Chanez, P, Heaney, L, Pavord, I, Quirce, S, Virchow, J, Holgate, S, Expert Group of the European Consensus Meeting for Severe Eosinophilic Asthma
Published 2017Journal article -
18
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model by Shukla S, Shah D, Martin A, Risebrough NA, Kendall R, Vogelmeier CF, Boucot I, Tombs L, Bjermer L, Jones PW, Kerwin E, Compton C, Maltais F, Lipson DA, Ismaila AS
Published 2021-11-01
Article -
19
Benralizumab for the prevention of COPD exacerbations by Criner, G, Celli, B, Brightling, C, Agusti, A, Papi, A, Singh, D, Sin, D, Vogelmeier, C, Sciurba, F, Bafadhel, M, Backer, V, Kato, M, Ramírez-Venegas, A, Wei, Y, Bjermer, L, Shih, V, Jison, M, O'Quinn, S, Makulova, N, Newbold, P, Goldman, M, Martin, U, Galathea and Terranova Study Investigators
Published 2019Journal article -
20
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy by Chen W, Sadatsafavi M, Tran TN, Murray RB, Wong CBN, Ali N, Ariti C, Garcia Gil E, Newell A, Alacqua M, Al-Ahmad M, Altraja A, Al-Lehebi R, Bhutani M, Bjermer L, Bjerrum AS, Bourdin A, Bulathsinhala L, von Bülow A, Busby J, Canonica GW, Carter V, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Yoo KH, Heaney LG, Heffler E, Hew M, Hilberg O, Hoyte F, Iwanaga T, Jackson DJ, Jones RC, Koh MS, Kuna P, Larenas-Linnemann D, Lehmann S, Lehtimäki LA, Lyu J, Mahboub B, Maspero J, Menzies-Gow AN, Sirena C, Papadopoulos N, Papaioannou AI, Pérez de Llano L, Perng DW, Peters M, Pfeffer PE, Porsbjerg CM, Popov TA, Rhee CK, Salvi S, Taillé C, Taube C, Torres-Duque CA, Ulrik CS, Ra SW, Wang E, Wechsler ME, Price DB
Published 2022-10-01
Article